EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

Core Viewpoint - EUDA Health Holdings Limited has successfully repurchased and cancelled a warrant previously issued to Streeterville Capital, LLC, eliminating potential share dilution and enhancing its financial position [1][3]. Group 1: Warrant Background - The warrant was part of a securities purchase agreement dated November 26, 2025, allowing for the purchase of up to 2,000,000 newly issued ordinary shares [2]. - The warrant underwent amendments on December 16, 2025, and January 13, 2026, prior to its repurchase [2]. Group 2: Repurchase Details - The total purchase price for the warrant repurchase was US$125,000, and the warrant has been fully cancelled, with no remaining warrants under this agreement [3]. - This transaction has completely eliminated the potential issuance of shares associated with the warrant [3]. Group 3: Company Overview - EUDA Health Holdings Limited is a leading non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China [4]. - The company aims to lead in the non-invasive and preventive healthcare sector, addressing the needs of over 1.8 billion people in a region with significant demographic shifts, including a rapidly aging population [4]. - EUDA is committed to transforming healthcare from reactive treatment to proactive, longevity-focused care, supported by innovative and science-backed health solutions [4].